97043 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants; Integrin superfamily Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
INTEGRIN BETA 2 (CD18) GENE-EDITED BOVINE CELLS AND ANIMALS WITH REDUCED SUSCEPTIBILITY TO MANNHEIMIA HAEMOLYTICA LEUKOTOXIN A (LKTA)
#2GENETICALLY ENGINEERED CELLS AND USES THEREOF
#3METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASE
#4T CELLS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF
#5TRANSDUCED T CELLS EXPRESSING HUMAN SSTR2 AND APPLICATION THEREOF
#6Reagents and assays using modified integrin domains
#7QUADRICISTRONIC SYSTEM COMPRISING A HOMING RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR FOR STABLE GENETIC MODIFICATION OF CELLULAR IMMUNOTHERAPIES
#8I DOMAIN CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO ICAM-1
#9Multimodal Vector for Dendritic Cell Infection
#10Transduced T cells expressing human SSTR2 and application thereof
#11T-cell modulatory multimeric polypeptides and methods of use thereof
#12Methods and compositions for promoting immune cell function
#13Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
#14IN VIVO PRIMING OF NATURAL KILLER CELLS
#15Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
#16Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
#17I domain chimeric antigen receptor specific to ICAM-1
#18COMPOSITIONS AND METHODS FOR TISSUE REPAIR
#19Engineered antigen presenting cells and uses thereof
#20Identification of Novel Small Molecule Beta2 Integrin Agonists
#21Method for producing protein
#22Transduced T cells expressing human SSTR2 and application thereof
#23I domain chimeric antigen receptor specific to ICAM-1
#24GENERATION OF HIGHLY POTENT ANTIBODIES NEUTRALIZING THE LUKGH (LUKAB) TOXIN OF STAPHYLOCOCCUS AUREUS
#25Method for producing protein
#26Compositions and methods for treating or preventing conditions and diseases associated with
#27PEPTIDIC ANTAGONISTS OF CLASS III SEMAPHORINS/NEUROPILINS COMPLEXES
#28Methods of treating and preventing infections and associated conditions
#29Compositions including I-domain antigen conjugate compounds and methods for treatment of autoimmune disorders
#30Compositions and methods for treating or preventing conditions and diseases associated with
#31METHODS AND REAGENTS FOR DETECTING SUSCEPTIBILITY TO GRAFT VERSUS HOST DISEASE OR TRANSPLANT RELATED MORTALITY
#32Compositions and methods for tissue repair
#33Peptidic antagonists of class III semaphorins/neuropilins complexes
#34Compounds and methods of modulating angiogenesis
#35Integrin-binding antibodies
#36Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality
#37Method for identifying an anti- streptococcal agent and its use for treating streptococcal infections
#38Soluble fibrin inhibitory peptides and uses thereof
#39Novel human beta-2 integrin alpha subunit
#40Myeloid cell promoter and constructs containing same
#41Signal-1/signal-2 bifunctional peptide inhibitors